BIO Policy Pulse: Phyllis Arthur Testifies on Need to Reauthorize PAHPA, Pass PASTEUR Act
The House Energy & Commerce Health Subcommittee held a hearing, Legislative Solutions to Bolster Preparedness and Response for All Hazards and Public Health Security Threats.
Phyllis Arthur, SVP of Infectious Disease and Emerging Science Policy at the Biotechnology Innovation Organization (BIO), testified about the importance of reauthorizing the Pandemic and All-Hazards Preparedness Act (PAHPA) and how the U.S. government can better prepare for the next pandemic.
Arthur noted that we could learn a lot about future pandemic preparedness from COVID-19, when we were able to develop and deliver vaccines in about 300 days.
Bio.News: https://bio.news/federal-policy/bios-...
June 13, 2023